D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 | +$601M | |
| 2 | +$510M | |
| 3 | +$502M | |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
+$490M |
| 5 |
TSMC
TSM
|
+$396M |
Top Sells
| 1 | +$967M | |
| 2 | +$951M | |
| 3 | +$567M | |
| 4 |
Eli Lilly
LLY
|
+$551M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| 1 | Technology | 20.32% |
| 2 | Healthcare | 13.21% |
| 3 | Consumer Discretionary | 12.32% |
| 4 | Financials | 8.58% |
| 5 | Industrials | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Berkshire Hathaway Class B
BRK.B
$1.07T
| $181M | 0.16% |
340,362
+53,426
|
|
||
102
C.H. Robinson
CHRW
$15.1B
| $180M | 0.16% |
1,754,751
+315,566
|
|
||
103
Novo Nordisk
NVO
$252B
| $179M | 0.16% |
2,582,572
+527,584
|
|
||
104
Kroger
KR
$45.8B
| $179M | 0.16% |
2,645,230
+906,023
|
|
||
105
Digital Realty Trust
DLR
$59.8B
| $179M | 0.16% |
1,246,464
+419,272
|
|
||
106
CRH
CRH
$79.5B
| $178M | 0.16% |
2,029,077
+51,085
|
|
||
107
Hims & Hers Health
HIMS
$14.2B
| $178M | 0.16% |
6,030,575
+5,390,213
|
|
||
108
IonQ
IONQ
$24B
| $175M | 0.16% |
7,939,705
+7,835,475
|
|
||
109
Cardinal Health
CAH
$37B
| $175M | 0.16% |
1,270,201
+248,790
|
|
||
110
IQVIA
IQV
$34.5B
| $172M | 0.15% |
977,779
+12,477
|
|
||
111
Dollar Tree
DLTR
$19.6B
| $172M | 0.15% |
2,287,435
-1,720,766
|
|
||
112
Cenovus Energy
CVE
$30.7B
| $172M | 0.15% |
12,337,616
-1,765,572
|
|
||
113
AT&T
T
$186B
| $171M | 0.15% |
6,032,192
-193,462
|
|
||
114
Ford
F
$46.8B
| $170M | 0.15% |
16,995,004
+9,051,749
|
|
||
115
Vanguard Short-Term Corporate Bond ETF
VCSH
$39.4B
| $169M | 0.15% |
2,146,600
-2,176,800
|
|
||
116
Salesforce
CRM
$225B
| $167M | 0.15% |
623,772
-353,504
|
|
||
117
Analog Devices
ADI
$117B
| $166M | 0.15% |
822,354
+367,844
|
|
||
118
General Dynamics
GD
$89.3B
| $164M | 0.15% |
601,809
+391,456
|
|
||
119
Centene
CNC
$17.6B
| $162M | 0.14% |
2,676,230
+105,156
|
|
||
120
Moderna
MRNA
$10.8B
| $160M | 0.14% |
5,636,151
+3,867,436
|
|
||
121
Tapestry
TPR
$24.2B
| $158M | 0.14% |
2,240,729
+2,181,914
|
|
||
122
JD.com
JD
$47B
| $156M | 0.14% |
3,796,673
-192,845
|
|
||
123
argenx
ARGX
$50.2B
| $154M | 0.14% |
260,325
-27,974
|
|
||
124
Pfizer
PFE
$139B
| $152M | 0.14% |
5,994,464
-1,712,316
|
|
||
125
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$18.1B
| $151M | 0.13% |
1,920,000
+53,000
|
|